Market Overview

Morning Market Losers

Related ARIA
ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure in Europe
Pacira's Exparel Positive In Phase IV Studies - Analyst Blog
Related LRN
Markets Edge Lower; Finish Line Earnings Beat Estimates
Grand Canyon Education Beats on Q1 Earnings & Rev - Analyst Blog

Ariad Pharmaceuticals (NASDAQ: ARIA) plummeted 72.81% to $4.66 after the company reported that it is pausing patient enrollment in studies of Iclusig.

K12 (NYSE: LRN) dropped 36.45% to $18.17 on lower outlook. BMO Capital downgraded the stock from Outperform to Market Perform.

Pretium Resources (NYSE: PVG) dropped 22.59% to $5.24. shares have dropped 49.78% over the past 52 weeks, while the S&P 500 index has gained 15.56% in the same period.

CytRx (NASDAQ: CYTR) dropped 18.07% to $2.2450 after the company priced its underwritten public offering of 10.0 million shares of common stock at a price of $2.25 per share.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Most Popular

Related Articles (ARIA + CYTR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free